Lusduna Nexvue

Despite scoring an FDA nod, Merck's biosim Lusduna must wait to challenge Lantus
Fierce Pharma
Sun, 07/23/17 - 11:40 am
FDA
Merck
biosimilars
Lusduna Nexvue
Lantus
diabetes
Sanofi
Hatch Waxman Act
Lawsuit stalls approval of Merck’s insulin injection
Drug Delivery Business News
Thu, 07/20/17 - 06:08 pm
Merck
insulin
diabetes
Lusduna Nexvue